On August 27, 2020 Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, reported that its Senior Vice President and Chief Financial Officer, Jonathan Guarino, will deliver a corporate presentation at the LD Micro Conference, held virtually September 1-4, 2020 (Press release, Soligenix, AUG 27, 2020, View Source [SID1234564127]). The presentation will be delivered on Friday, September 4 at 9:40 AM ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

For more information about the LD Micro Conference, please refer to the conference website at View Source

For further information regarding Soligenix, Inc., please visit the Company’s website at www.soligenix.com.